A detailed history of Pictet Asset Management Sa transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Pictet Asset Management Sa holds 5,057 shares of PRTA stock, worth $77,119. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,057
Holding current value
$77,119
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$48.26 - $78.59 $244,050 - $397,429
5,057 New
5,057 $345,000
Q4 2022

Feb 13, 2023

BUY
$52.05 - $65.0 $211,687 - $264,355
4,067 New
4,067 $245,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $716M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.